IL-23: a master regulator in Crohn disease
- 1 January 2007
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 13 (1) , 26-27
- https://doi.org/10.1038/nm0107-26
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease GeneScience, 2006
- Interleukin-23 drives innate and T cell–mediated intestinal inflammationThe Journal of Experimental Medicine, 2006
- IL-23 plays a key role inHelicobacter hepaticus–induced T cell–dependent colitisThe Journal of Experimental Medicine, 2006
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune PathologyImmunity, 2006
- IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6Journal of Clinical Investigation, 2006
- Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cellsJournal of Clinical Investigation, 2003
- Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12Immunity, 2000
- T Cell–mediated Pathology in Two Models of Experimental Colitis Depends Predominantly on the Interleukin 12/Signal Transducer and Activator of Transcription (Stat)-4 Pathway, but Is Not Conditional on Interferon γ Expression by T CellsThe Journal of Experimental Medicine, 1998
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995